<!DOCTYPE HTML><html>
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>Real Estate Report</title>
   </head>
   <style>
      table {
         border: 2px solid rgb(18, 139, 219);
         border-collapse: collapse;
         width: 100%;
         text-align: center;
         background-color: #ceecff;
      }

      th, td {
         border: 1px solid rgb(18, 139, 219);
         
      }
   </style>
   <body>
      <center>
         <h2>Tabla de bacterias</h2>
      </center>
      <table>
         <thead>
            <tr>
               <th>Field</th>
               <th>Distribution</th>
               <th>Unit</th>
               <th>Time</th>
               <th>RegionName</th>
               <th>Category</th>
               <th>Value</th>
               <th>Nombre Bacteria</th>
               <th>Antibiotico testado</th>
            </tr>
         </thead>
         <tbody>
            <tr>
               <td>32</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>7.142857143</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>109</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>110</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>111</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>112</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.545454545</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>196</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>197</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>198</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>199</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.882352941</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>289</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>290</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>291</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>9.523809524</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>377</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>378</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.555555556</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>464</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>465</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>466</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>561</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>562</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>563</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>602</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.666666667</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>603</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>640</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.263157895</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>641</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>686</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>687</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.555555556</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>734</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>735</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>16.666666667</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>782</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>783</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>828</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>829</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>880</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>881</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>922</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>923</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>924</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>925</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>999</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1000</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1001</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1002</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1090</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1091</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1092</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1093</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.555555556</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1183</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1184</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1185</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>9.523809524</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1273</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1274</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1359</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1360</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1361</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1454</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1455</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1456</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1495</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1496</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1533</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1534</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1579</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1580</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.263157895</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1627</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1628</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>16.666666667</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1675</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1676</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1723</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1724</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1773</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1774</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>1818</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1819</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1820</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1821</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1895</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1896</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1897</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1898</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1982</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1983</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1984</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>1985</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.882352941</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2073</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2074</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2075</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>9.523809524</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2161</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2162</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2248</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2249</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2250</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2343</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2344</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2345</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2384</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2385</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2422</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2423</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2468</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2469</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.555555556</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2516</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2517</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>16.666666667</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2564</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2565</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2610</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2611</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2660</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2661</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Combined resistance (fluoroquinolones, aminoglycosides and carbapenems)</td>
            </tr>
            <tr>
               <td>2701</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2702</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2703</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2704</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2778</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2779</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2780</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2781</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2869</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2870</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2871</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2872</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>11.111111111</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2962</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2963</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>2964</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>9.523809524</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3050</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3051</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.555555556</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3139</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3140</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3141</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3236</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3237</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3238</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3277</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3278</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3315</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3316</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3361</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.666666667</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3362</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.263157895</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3409</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3410</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>16.666666667</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3457</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.846153846</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3458</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3505</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3506</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3557</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3558</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Acinetobacter spp.</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>3577</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3578</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3579</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.523809524</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3580</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3628</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3629</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3630</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.692307692</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3631</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3710</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3711</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3712</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3795</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3796</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3797</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3798</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3880</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3881</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3882</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3963</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3964</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3965</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.083333333</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>3966</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.069518717</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4060</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4061</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4062</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.5625</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4063</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.502512563</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4158</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4159</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>33.333333333</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4160</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.162790698</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4161</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.363636364</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4255</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4256</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4257</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4258</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.471698113</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4349</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4350</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4351</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4448</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4449</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4450</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4451</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4544</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4545</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4546</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4547</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4644</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4645</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4646</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.833333333</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4647</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.086956522</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4746</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4747</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4748</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4749</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.549450549</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4853</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4854</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4855</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4856</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.497512438</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4960</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4961</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4962</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.952380952</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>4963</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.317460317</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5068</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5069</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5070</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.961538462</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5071</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5178</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5179</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5180</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5181</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5285</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5286</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5287</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5288</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5314</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.174603175</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5315</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5346</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.298701299</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5347</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.222222222</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5392</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5393</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5440</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5441</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5488</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5489</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5536</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.584795322</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5537</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.225806452</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5592</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.985221675</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5593</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5646</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.260504202</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5647</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.898550725</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5700</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5701</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.315789474</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5754</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5755</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5808</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5809</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5860</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5861</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5916</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.086956522</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5917</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.746268657</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5974</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.276243094</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>5975</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.746268657</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6030</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.261780105</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6031</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.657894737</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6086</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.316455696</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6087</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.826446281</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6142</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6143</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.854700855</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6198</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6199</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6254</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6255</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>6310</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6311</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>75.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6312</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>35.294117647</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6379</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6380</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6381</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>40.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6382</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>32.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6456</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>12.5</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6457</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>47.619047619</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6536</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>25.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6537</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>27.586206897</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6617</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6618</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>44.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6619</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>29.032258065</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6704</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6705</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6706</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>29.166666667</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6707</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>34.567901235</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6792</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6793</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>100.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6794</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>34.090909091</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6795</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>34.234234234</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6885</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>50.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6886</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6887</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>25.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6888</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>30.612244898</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6968</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>40.322580645</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>6969</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>34.210526316</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7056</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>16.666666667</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7057</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7058</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>38.636363636</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7059</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>33.532934132</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7146</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7147</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7148</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>30.769230769</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7149</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>19.76744186</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7241</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>50.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7242</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>31.818181818</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7243</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>28.865979381</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7336</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>50.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7337</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>26.086956522</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7338</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>26.666666667</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7431</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>20.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7432</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7433</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>25.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7434</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>19.21182266</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7526</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>14.285714286</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7527</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7528</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.142857143</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7529</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>10.714285714</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7622</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7623</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7624</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>20.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7625</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>15.384615385</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7723</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7724</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7725</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.01754386</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7726</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>17.647058824</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7821</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7822</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>16.326530612</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7823</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>12.804878049</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7873</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>43.75</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7874</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>37.5</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7917</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>31.818181818</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7918</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>33.333333333</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7961</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>34.782608696</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>7962</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>75.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8009</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>28.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8010</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>25.0</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8057</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>32.258064516</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8058</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>30.769230769</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8109</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>34.117647059</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8110</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>27.272727273</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8157</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>34.645669291</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8158</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>32.352941176</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8209</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>30.281690141</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8210</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>27.272727273</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8257</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>38.418079096</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8258</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>29.333333333</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8307</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>34.705882353</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8308</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>31.25</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8357</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>22.368421053</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8358</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>20.512820513</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8411</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>30.337078652</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8412</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>29.411764706</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8467</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>29.166666667</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8468</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>20.833333333</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8521</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>21.354166667</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8522</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>19.230769231</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8573</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>11.206896552</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8574</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.382978723</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8623</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>16.201117318</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8624</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>14.285714286</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8675</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>14.556962025</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8676</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>13.793103448</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8727</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>11.976047904</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8728</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>18.367346939</td>
               <td>Enterococcus faecalis</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>8745</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8746</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8747</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.692307692</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8748</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8796</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8797</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8798</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8799</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.369863014</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8878</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8879</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8880</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8881</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.5</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8963</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8964</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8965</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>8966</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9048</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9049</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9050</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9130</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9131</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9132</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9133</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9226</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9227</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9228</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9229</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9327</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9328</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9329</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9330</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9425</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9426</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9427</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9428</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9519</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9520</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9521</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9618</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9619</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9620</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9714</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9715</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9716</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9814</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>8.333333333</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9815</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9816</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9817</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9916</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9917</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9918</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>9919</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10023</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10024</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10025</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10026</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10130</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10131</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10132</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10133</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10238</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10239</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10240</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10241</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10348</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10349</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10350</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10351</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10455</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10456</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10457</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10458</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10484</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10485</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.882352941</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10516</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.639344262</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10517</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10562</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10563</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.333333333</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10610</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10611</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10658</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10659</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10706</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10707</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10762</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10763</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10816</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10817</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10870</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10871</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10924</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10925</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10978</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>10979</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11030</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11031</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11088</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11089</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.763358779</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11146</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11147</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11202</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11203</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11258</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11259</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11314</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11315</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11370</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11371</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11426</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11427</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecalis</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>11440</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11441</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>66.666666667</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11442</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>20.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11468</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>33.333333333</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11469</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>7.692307692</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11530</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11531</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>28.571428571</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11532</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>22.727272727</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11586</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>28.571428571</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11587</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>36.666666667</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11651</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11652</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>66.666666667</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11721</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>72.222222222</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11722</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>59.574468085</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11800</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11801</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>76.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11802</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>73.333333333</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11882</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>89.285714286</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11883</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>76.056338028</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11963</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>81.578947368</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>11964</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>72.972972973</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12044</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>50.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12045</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>79.310344828</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12046</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>75.342465753</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12130</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>66.666666667</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12131</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12132</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>95.918367347</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12133</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>78.048780488</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12226</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12227</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12228</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>82.692307692</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12229</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>71.818181818</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12317</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12318</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>87.272727273</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12319</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>81.415929204</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12413</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12414</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12415</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>85.507246377</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12416</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>87.943262411</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12512</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12513</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>90.410958904</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12514</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>82.352941176</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12611</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12612</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12613</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>94.827586207</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12614</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>82.258064516</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12711</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12712</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>89.393939394</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>80.136986301</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12808</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12809</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>77.142857143</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12810</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>74.637681159</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12908</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12909</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>83.018867925</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12910</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>71.666666667</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12933</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>30.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12934</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>33.333333333</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12949</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>23.076923077</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12950</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>16.666666667</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12985</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>26.923076923</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>12986</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>18.181818182</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13017</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>35.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13018</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>35.294117647</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13057</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>82.352941176</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13058</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>60.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13098</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>63.414634146</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13099</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>66.666666667</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13144</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>76.19047619</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13145</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>75.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13194</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>77.777777778</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13195</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>81.395348837</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13244</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>76.19047619</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13245</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>75.510204082</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13292</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>77.777777778</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13293</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>73.170731707</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13342</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>87.5</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13343</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>80.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13396</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>81.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13397</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>65.625</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13452</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>81.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13453</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>85.507246377</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13510</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>84.558823529</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13511</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>92.207792208</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13566</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>85.507246377</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13567</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>83.333333333</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13620</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>84.347826087</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13621</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>90.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13676</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>85.820895522</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13677</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>77.5</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13730</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>80.0</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13731</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>67.088607595</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13786</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>78.899082569</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>13787</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>69.230769231</td>
               <td>Enterococcus faecium</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>14038</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>50.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14039</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>40.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14108</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>63.636363636</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14109</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>33.333333333</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14183</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>73.333333333</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14184</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>44.680851064</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14257</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>47.619047619</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14258</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>56.896551724</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14330</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14331</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>55.555555556</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14332</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>30.952380952</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14408</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14409</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14410</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>66.666666667</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14411</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>55.555555556</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14495</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>42.857142857</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14496</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>43.181818182</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14577</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14578</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>46.666666667</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14579</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>33.333333333</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14661</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14662</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>44.444444444</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14663</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>47.457627119</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14752</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14753</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>52.631578947</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14754</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>33.783783784</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14840</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14841</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14842</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>64.516129032</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14843</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>33.333333333</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14926</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>61.111111111</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>14927</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>42.372881356</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15010</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>52.173913043</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15011</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>32.857142857</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15099</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15100</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>51.612903226</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15101</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>23.529411765</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15267</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>48.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15268</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>28.571428571</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15313</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>41.176470588</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15314</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>50.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15361</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>45.454545455</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15362</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>58.620689655</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15409</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>57.777777778</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15410</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>50.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15455</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>33.333333333</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15456</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>45.454545455</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15503</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>57.894736842</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15504</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>58.333333333</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15553</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>57.142857143</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15554</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>21.739130435</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15605</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>42.857142857</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15606</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>28.571428571</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15659</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>48.275862069</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15660</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>44.827586207</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15713</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>42.028985507</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15714</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>36.363636364</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15763</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>42.592592593</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15764</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>46.428571429</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15813</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>48.333333333</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15814</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>51.428571429</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15863</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>45.205479452</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15864</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>32.558139535</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15915</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>36.206896552</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15916</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>28.0</td>
               <td>Enterococcus faecium</td>
               <td>High-level gentamicin</td>
            </tr>
            <tr>
               <td>15927</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>15928</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>15929</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>15957</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>15958</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16019</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16020</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16021</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16074</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16075</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16140</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16141</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16208</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16209</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16285</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16286</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16287</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16370</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16371</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16452</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16453</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16534</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16535</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16536</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16623</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16624</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16625</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16626</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16719</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16720</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16721</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.960784314</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16722</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.785714286</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16810</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16811</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.818181818</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16812</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16906</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16907</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16908</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.47761194</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>16909</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.418439716</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17005</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17006</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.109589041</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17007</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.657894737</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17105</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17106</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17107</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17108</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17204</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17205</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.985074627</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17206</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.388888889</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17301</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17302</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.797101449</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17303</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.787878788</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17401</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17402</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.773584906</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17403</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.709401709</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17426</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17427</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17444</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17445</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17480</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17481</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17512</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17513</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17552</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17553</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17591</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17592</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17639</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17640</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17691</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17692</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17741</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17742</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17789</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17790</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17841</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.234567901</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17842</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17895</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.941176471</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17896</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17951</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>17952</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.449275362</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18009</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.222222222</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18010</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.631578947</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18065</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.189781022</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18066</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.111111111</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18119</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18120</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18175</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.503759398</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18176</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.5</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18229</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.651162791</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18230</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.109589041</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18285</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18286</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.25</td>
               <td>Enterococcus faecium</td>
               <td>Vancomycin</td>
            </tr>
            <tr>
               <td>18307</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18308</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18309</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.552486188</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18310</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.192842942</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18364</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18365</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18366</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.604278075</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18367</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.509337861</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18454</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18455</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18456</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.803212851</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18457</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.701262272</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18554</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18555</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18556</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.673400673</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18557</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.377833753</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18653</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.347826087</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18654</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18655</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.22324159</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18656</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.484261501</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18757</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>5.263157895</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18758</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18759</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.312138728</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18760</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.475237092</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18862</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18863</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>6.666666667</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18864</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.181818182</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18865</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.374885426</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18968</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.166666667</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18969</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18970</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.803131991</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>18971</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.687296417</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19075</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19076</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>10.526315789</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19077</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.578947368</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19078</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.06122449</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19179</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>3.448275862</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19180</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19181</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.80349345</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19182</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.82108389</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19286</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>20.512820513</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19287</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>9.090909091</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19288</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.042016807</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19289</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.62273579</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19396</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>10.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19397</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19398</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.053598775</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19399</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.674392312</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19506</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>3.846153846</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19507</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>7.692307692</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19508</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.955936353</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19509</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.934210526</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19617</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>10.416666667</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19618</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>10.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19619</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.980049875</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19620</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.684402001</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19728</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.127659574</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19729</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>13.043478261</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19730</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.417112299</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19731</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.758077879</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19844</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.255319149</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19845</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19846</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.37704918</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19847</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.602358888</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19959</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19960</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.846153846</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19961</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.376518219</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>19962</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.335968379</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20073</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>14.285714286</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20074</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>10.344827586</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20075</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.710743802</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20076</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.084359836</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20189</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>13.20754717</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20190</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>6.896551724</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20191</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.166495375</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20192</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.451327434</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20219</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.27100271</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20220</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.792114695</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20249</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.744416873</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20250</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.617283951</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20297</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.779727096</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20298</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.755667506</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20349</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.333333333</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20350</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.455580866</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20401</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.16025641</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20402</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.209677419</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20453</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.586510264</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20454</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.871621622</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20511</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.349831271</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20512</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.396166134</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20567</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.356902357</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20568</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.439153439</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20621</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.57997936</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20622</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.034229829</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20675</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.639296188</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20676</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.921568627</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20729</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.770986145</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20730</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.090373281</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20785</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.223388306</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20786</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.110132159</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20843</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.425867508</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20844</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.11961057</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20901</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.730478589</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20902</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.109322602</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20957</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.847085978</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>20958</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.058125741</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21013</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.170387779</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21014</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.879299562</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21069</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.369863014</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21070</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.645612074</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21125</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.818181818</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21126</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.537154989</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21181</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.585265327</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21182</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.914344685</td>
               <td>Escherichia coli</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>21197</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>27.339901478</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21198</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>22.392638037</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21227</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>31.971153846</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21228</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>21.686746988</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21275</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>31.853281853</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21276</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>22.828784119</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21327</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>37.321428571</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21328</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>28.255528256</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21379</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>32.532051282</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21380</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>29.208924949</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21431</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>35.682819383</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21432</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>31.641285956</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21489</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>35.986547085</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21490</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>31.68</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21545</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>39.125560538</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21546</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>38.095238095</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21599</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>37.010309278</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21600</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>38.386308068</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21653</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>38.304093567</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21654</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>35.784313725</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21707</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>38.137651822</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21708</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>38.275193798</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21761</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>38.075017693</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21762</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>40.315876974</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21819</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>43.039591315</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21820</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>43.456962911</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21877</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>41.720154044</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21878</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>44.307270233</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21933</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>40.266512167</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21934</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>43.384982122</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21987</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>44.503233392</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>21988</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>47.183979975</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>22043</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>42.136986301</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>22044</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>43.631284916</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>22097</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>40.367965368</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>22098</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>43.919277748</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>22151</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>40.443070582</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>22152</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>44.117647059</td>
               <td>Escherichia coli</td>
               <td>Aminopenicillins</td>
            </tr>
            <tr>
               <td>22166</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22167</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22168</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22169</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.233100233</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22217</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22218</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22219</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22220</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22271</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22272</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>14.285714286</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22273</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22274</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22342</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22343</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22344</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22345</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22413</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22414</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22415</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22416</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22493</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22494</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22495</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22496</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22579</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22580</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22581</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.263157895</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22582</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22667</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22668</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22669</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22670</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22763</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22764</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22765</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22766</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.091324201</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22856</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22857</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22858</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22859</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22960</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22961</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22962</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>22963</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23062</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23063</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23064</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.147710487</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23065</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23168</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23169</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23170</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23171</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23275</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23276</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23277</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23278</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.090950432</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23383</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23384</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23385</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23386</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23495</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23496</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23497</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23498</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.042176297</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23606</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23607</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23608</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23609</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.078988942</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23716</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23717</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23718</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.103305785</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23719</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.074626866</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23830</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23831</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23832</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23833</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.035410765</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23862</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23863</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.396825397</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23890</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23891</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23920</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.25</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23921</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23958</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23959</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23996</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>23997</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24040</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24041</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24086</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.124843945</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24087</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24134</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24135</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24186</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.119904077</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24187</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24236</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24237</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24290</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24291</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24342</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.071684588</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24343</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24398</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24399</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24454</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.062972292</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24455</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.067069081</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24510</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24511</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24564</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24565</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.062578223</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24618</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.054794521</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24619</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.055834729</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24672</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24673</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.159320234</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24728</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.051519835</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24729</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>24749</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24750</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24751</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24752</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.22675737</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24806</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24807</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24808</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24809</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24896</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24897</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24898</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24899</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24996</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24997</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24998</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.380228137</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>24999</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25095</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.347826087</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25096</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25097</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.344827586</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25098</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25199</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25200</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25201</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.320512821</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25202</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.229885057</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25304</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25305</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25306</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.487804878</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25307</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.292397661</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25409</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25410</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25411</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.705882353</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25412</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.672834315</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25516</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25517</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>5.555555556</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25518</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.8492569</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25519</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.789265983</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25620</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>3.448275862</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25621</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25622</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.877192982</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25623</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.524344569</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25726</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.702702703</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25727</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25728</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.854974705</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25729</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.191222571</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25836</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25837</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25838</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.683501684</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25839</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.109057301</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25946</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25947</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>8.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25948</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.770448549</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>25949</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.598401598</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26057</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>8.695652174</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26058</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.571428571</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26059</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.570694087</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26060</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.312411515</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26167</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26168</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26169</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.248394004</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26170</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.908713693</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26283</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26284</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26285</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.992966002</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26286</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.937657961</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26398</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26399</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.846153846</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26400</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.129817444</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26401</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.898734177</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26512</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>1.785714286</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26513</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26514</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.412616339</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26515</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.054538663</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26628</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>7.843137255</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26629</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26630</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.055498458</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26631</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.912858661</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26658</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26659</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.383141762</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26688</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26689</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26736</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26737</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26788</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26789</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.25</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26840</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26841</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26892</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26893</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.537634409</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26950</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.234192037</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>26951</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.494233937</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27006</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.343249428</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27007</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.085481682</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27060</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.726141079</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27061</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.986436498</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27114</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.294695481</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27115</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.991325898</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27168</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.818330606</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27169</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.974333662</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27224</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.568181818</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27225</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.046783626</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27282</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.549865229</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27283</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.36861584</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27340</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.095612312</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27341</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.908587258</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27396</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.502890173</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27397</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.436125966</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27452</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.530311948</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27453</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.313946216</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27508</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.754385965</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27509</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.128851541</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27564</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.164502165</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27565</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.604997342</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27620</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.444043321</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27621</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.582644628</td>
               <td>Escherichia coli</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>27642</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27643</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27644</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.904761905</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27645</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.654411765</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27699</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27700</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27701</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.551020408</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27702</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.963081862</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27789</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27790</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27791</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.521008403</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27792</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.517241379</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27889</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27890</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>7.692307692</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27891</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.272727273</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27892</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.308900524</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27988</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.347826087</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27989</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27990</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.72972973</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>27991</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.041720991</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28092</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28093</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28094</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.324840764</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28095</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.903559127</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28198</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>16.666666667</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28199</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>13.333333333</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28200</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.126213592</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28201</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.766536965</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28303</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.166666667</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28304</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28305</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>8.235294118</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28306</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.806722689</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28410</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28411</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>11.111111111</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28412</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>8.917197452</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28413</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.855791962</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28514</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>6.896551724</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28515</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28516</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.170305677</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28517</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>8.607784431</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28620</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>5.128205128</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28621</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>9.090909091</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28622</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.887772194</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28623</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>8.024691358</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28730</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28731</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28732</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.843373494</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28733</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>8.514190317</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28840</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28841</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>8.0</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28842</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>13.929040736</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28843</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>10.563029397</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28951</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>13.043478261</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28952</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>17.857142857</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28953</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.756097561</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>28954</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>11.168708765</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29062</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>6.52173913</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29063</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>8.695652174</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29064</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>12.393162393</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29065</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>10.580912863</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29178</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.222222222</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29179</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.846153846</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29180</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>13.130128957</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29181</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>9.393428812</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29293</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>1.470588235</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29294</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.846153846</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29295</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>11.144883485</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29296</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>11.190193752</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29407</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>8.928571429</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29408</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>10.344827586</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29409</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>16.012396694</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29410</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>12.808065721</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29523</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>9.803921569</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29524</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>6.896551724</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29525</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>14.08016444</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29526</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>12.57082153</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29553</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.492537313</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29554</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.127659574</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29583</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.126126126</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29584</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.420454545</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29631</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.512287335</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29632</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.216748768</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29683</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.666666667</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29684</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.137767221</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29735</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.327787022</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29736</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.25210084</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29787</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.527607362</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29788</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.082289803</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29845</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.545454545</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29846</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.10708402</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29901</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.285714286</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29902</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.598371777</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29955</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.383022774</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>29956</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>9.741060419</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30009</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>7.058823529</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30010</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>10.643564356</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30063</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.320907618</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30064</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>11.531007752</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30119</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.48011782</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30120</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>11.954624782</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30177</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>7.940780619</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30178</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>14.959469418</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30235</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.817766166</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30236</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>13.088642659</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30291</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.37666089</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30292</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>13.717339667</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30347</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>7.357268982</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30348</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>13.258286429</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30403</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.219178082</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30404</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>13.717805151</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30459</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>10.432432432</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30460</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>16.640085061</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30515</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>9.639175258</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30516</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>16.064049587</td>
               <td>Escherichia coli</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>30536</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.545454545</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30537</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30538</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.425531915</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30539</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.153846154</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30593</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30594</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30595</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30596</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.417246175</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30683</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30684</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30685</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.367647059</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30686</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.122699387</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30783</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30784</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>7.692307692</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30785</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.325732899</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30786</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.118906064</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30882</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.347826087</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30883</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30884</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.201201201</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30885</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.237529691</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30986</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30987</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30988</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.578034682</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>30989</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.949367089</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31095</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>8.333333333</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31096</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>6.666666667</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31097</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.267573696</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31098</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.823421775</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31201</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31202</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31203</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.232142857</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31204</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.196908055</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31308</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>3.448275862</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31309</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>10.526315789</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31310</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.736842105</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31311</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.351097179</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31412</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>3.333333333</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31413</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31414</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.260869565</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31415</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.927353595</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31519</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.5</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31520</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31521</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.010016694</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31522</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.892307692</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31629</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31630</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>5.263157895</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31631</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.870624049</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31632</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.248898678</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31736</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>5.769230769</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31737</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>7.692307692</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31738</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.493857494</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31739</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.85519511</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31847</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>12.5</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31848</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.333333333</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31849</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.347447073</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31850</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.735883424</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31957</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.127659574</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31958</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>4.347826087</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31959</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.510138741</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>31960</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.592377796</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32073</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>6.382978723</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32074</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32075</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.791569087</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32076</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.812973884</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32188</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.347826087</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32189</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.846153846</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32190</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.875631951</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32191</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.09478673</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32302</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>7.142857143</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32303</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32304</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>8.255933953</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32305</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.037313433</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32418</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>13.20754717</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32419</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>3.448275862</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32420</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.269270298</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32421</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.83427762</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32448</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.220264317</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32449</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.268817204</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32478</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.607287449</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32479</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32526</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32527</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.44345898</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32578</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32579</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.436681223</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32630</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.313971743</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32631</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.396825397</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32682</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.147058824</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32683</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.686340641</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32740</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.01010101</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32741</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.597444089</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32796</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.791713326</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32797</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.645502646</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32850</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.7507724</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32851</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.422982885</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32904</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.461988304</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32905</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.182374541</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32958</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.580645161</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>32959</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.932301741</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33014</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.564102564</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33015</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.92653414</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33072</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.232469994</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33073</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.640668524</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33130</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.287515763</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33131</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.841046278</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33186</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.440599769</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33187</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.172495554</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33242</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.879482657</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33243</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.25</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33298</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.709748083</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33299</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.420993858</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33354</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.864864865</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33355</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.847133758</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33410</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.257731959</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33411</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>8.204334365</td>
               <td>Escherichia coli</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>33478</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>50.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33479</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>8.163265306</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33480</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.704225352</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33566</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33567</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33568</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33569</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.571428571</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33667</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33668</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33669</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33670</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.913242009</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33766</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33767</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33768</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.105263158</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33769</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.214574899</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33860</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33861</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>25.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33862</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.542056075</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33863</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.423487544</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33962</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33963</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33964</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.521126761</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>33965</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.94637224</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34068</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34069</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34070</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.255639098</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34071</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.135888502</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34171</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34172</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34173</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.183431953</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34174</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.477477477</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34278</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34279</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>20.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34280</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.658536585</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34281</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.70575693</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34384</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34385</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34386</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.166666667</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34387</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.963235294</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34491</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34492</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34493</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.389830508</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34494</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.50877193</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34604</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34605</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>16.666666667</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34606</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.304147465</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34607</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.658536585</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34712</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34714</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.673796791</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34715</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.599659284</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34823</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>10.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34824</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34825</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.357142857</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34826</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.197132616</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34881</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.830188679</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34882</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.469135802</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34931</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.699300699</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34932</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34985</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.156069364</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>34986</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35039</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.408450704</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35040</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.492537313</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35091</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.913043478</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35092</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.840490798</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35145</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.444043321</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35146</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.07253886</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35201</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.43902439</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35202</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35259</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.849002849</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35260</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.84501845</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35317</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.174603175</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35318</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.127819549</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35373</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.105263158</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35374</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.602230483</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35429</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.866180049</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35430</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.730103806</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35485</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.182509506</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35486</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.766784452</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35541</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.980079681</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35542</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.867383513</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35597</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.934065934</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35598</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.255319149</td>
               <td>Klebsiella pneumoniae</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>35660</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35661</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.222222222</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35662</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35743</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35744</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.408450704</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35745</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35831</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35832</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35833</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35834</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35925</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35926</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35927</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.204819277</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>35928</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.4784689</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36012</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36013</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36014</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36015</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36110</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36111</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36112</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36113</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36213</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36214</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36215</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36216</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36313</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>16.666666667</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36314</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36315</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.591715976</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36316</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.224719101</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36418</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36419</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36420</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36421</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.212765957</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36522</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36523</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36524</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36525</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36625</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36626</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36627</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.564971751</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36628</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36736</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36737</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36738</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36739</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36841</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36842</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36843</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36844</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36950</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36951</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36952</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>36953</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.179533214</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37006</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.176470588</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37007</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37054</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37055</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.052631579</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37104</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37105</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37156</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37157</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.694915254</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37206</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37207</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37258</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37259</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37312</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37313</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37368</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.568181818</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37369</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.36900369</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37424</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37425</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.374531835</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37478</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37479</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37532</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37533</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.346020761</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37586</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37587</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37640</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37641</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37694</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37695</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.354609929</td>
               <td>Klebsiella pneumoniae</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>37762</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37763</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37764</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37850</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37851</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37852</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37853</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37948</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37949</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37950</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>37951</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38046</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38047</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38048</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.063829787</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38049</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.406504065</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38139</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38140</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38141</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.672897196</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38142</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.35971223</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38240</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38241</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38242</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.127659574</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38243</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.634920635</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38346</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38347</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38348</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.801801802</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38349</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.389105058</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38449</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38450</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38451</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.242236025</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38452</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.654846336</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38560</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38561</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>20.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38562</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.53164557</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38563</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.342281879</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38665</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38666</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38667</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.083333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38668</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.411764706</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38772</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38773</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38774</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.694915254</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38775</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.5390625</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38885</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38886</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38887</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.382488479</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38888</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.146853147</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38993</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38994</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38995</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.139037433</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>38996</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.577512777</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39104</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>11.111111111</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39105</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39106</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.796407186</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39107</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.301075269</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39162</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39163</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39212</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39213</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39266</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39267</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39320</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39321</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.503759398</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39372</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.620087336</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39373</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39426</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.364963504</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39427</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.07253886</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39482</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.460829493</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39483</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.27388535</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39540</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.102102102</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39541</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.769230769</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39598</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.521008403</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39599</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.772200772</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39654</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.263157895</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39655</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.486988848</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39710</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.919708029</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39711</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.388888889</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39766</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.435114504</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39767</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.060070671</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39822</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.585657371</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39823</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.508960573</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39878</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.298013245</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39879</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.418439716</td>
               <td>Klebsiella pneumoniae</td>
               <td>Combined resistance (third-generation cephalosporin, fluoroquinolones and aminoglycoside)</td>
            </tr>
            <tr>
               <td>39946</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>39947</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.173913043</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>39948</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.806451613</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40034</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40035</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40036</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.41025641</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40037</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>7.272727273</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40134</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40135</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40136</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.296703297</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40137</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.213270142</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40232</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40233</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40234</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.210526316</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40235</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.658536585</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40325</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40326</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40327</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>11.111111111</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40328</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.597122302</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40426</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40427</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>16.666666667</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40428</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>13.194444444</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40429</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.716981132</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40532</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40533</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40534</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.875968992</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40535</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.424657534</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40635</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>50.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40636</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40637</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.726708075</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40638</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.521126761</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40742</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40743</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>20.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40744</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.696202532</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40745</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.474272931</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40848</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40849</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40850</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.663212435</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40851</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.617647059</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40955</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40956</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40957</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.95480226</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>40958</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.263157895</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41068</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41069</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41070</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.225806452</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41071</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.886561955</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41176</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41177</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41178</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.160427807</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41179</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>10.391822828</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41287</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>22.222222222</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41288</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>100.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41289</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>12.574850299</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41290</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>12.903225806</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41345</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41346</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.597402597</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41395</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.142857143</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41396</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.603773585</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41449</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.761904762</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41450</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.411764706</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41503</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.877934272</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41504</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.015037594</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41555</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.423580786</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41556</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.086419753</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41609</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.857142857</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41610</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.666666667</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41665</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.06504065</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41666</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.762430939</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41723</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.776119403</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41724</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.0651341</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41781</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.602240896</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41782</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.861003861</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41837</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.157894737</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41838</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.42804428</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41893</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.569343066</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41894</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.76816609</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41949</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.34351145</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>41950</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.464788732</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>42005</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>11.553784861</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>42006</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>7.885304659</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>42061</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>14.12803532</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>42062</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>11.34751773</td>
               <td>Klebsiella pneumoniae</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>42129</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>50.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42130</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.081632653</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42131</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.704225352</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42217</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42218</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42219</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.43902439</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42220</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.142857143</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42317</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42318</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42319</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.052631579</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42320</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.369863014</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42416</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42417</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42418</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.083333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42419</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.619433198</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42510</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42511</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42512</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.555555556</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42513</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.773049645</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42612</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42613</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42614</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.137931034</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42615</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.25</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42718</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42719</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42720</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.149606299</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42721</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.777777778</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42821</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>16.666666667</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42822</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42823</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.366863905</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42824</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.386004515</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42928</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>16.666666667</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42929</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>20.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42930</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.87804878</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>42931</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.404255319</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43033</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43034</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43035</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.18134715</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43036</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.066176471</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43140</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43141</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43142</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.519774011</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43143</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.058365759</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43253</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43254</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43255</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.373271889</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43256</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.381944444</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43361</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43362</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>100.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43363</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.347593583</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43364</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.621805792</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43472</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>20.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43473</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>100.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43474</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.952380952</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43475</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>7.52688172</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43530</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.943396226</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43531</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.469135802</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43580</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.797202797</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43581</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43634</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.312138728</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43635</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.724637681</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43688</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.401869159</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43689</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.23880597</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43740</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.782608696</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43741</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43794</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.120141343</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43795</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.051282051</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43850</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.489626556</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43851</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.333333333</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43908</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.273504274</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43909</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.851851852</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43966</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.761904762</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>43967</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.996254682</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44022</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.578947368</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44023</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.95202952</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44078</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.839416058</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44079</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.793103448</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44134</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.034220532</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44135</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.50877193</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44190</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.374501992</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44191</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.659498208</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44246</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>8.131868132</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44247</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.382978723</td>
               <td>Klebsiella pneumoniae</td>
               <td>Third-generation cephalosporins</td>
            </tr>
            <tr>
               <td>44311</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44312</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44313</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44394</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44395</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44396</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44487</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44488</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.703703704</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44489</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44572</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44573</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44574</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44575</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.970873786</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44664</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44665</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44666</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44667</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44762</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44763</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44764</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44765</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.862068966</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44865</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44866</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44867</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44965</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44966</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44967</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.960784314</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>44968</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.71942446</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45067</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45068</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45069</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.083333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45070</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.428571429</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45171</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45172</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>20.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45173</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45174</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.156069364</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45278</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45279</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45280</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.5625</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45281</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.680272109</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45386</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45387</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45388</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.571428571</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45389</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45490</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45491</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45492</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45493</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.714285714</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45601</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45602</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45603</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.960784314</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45604</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.564971751</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45657</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45658</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45705</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.886792453</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45706</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45757</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.408450704</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45758</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45803</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45804</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.040816327</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45855</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45856</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45909</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45910</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.886792453</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45965</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>45966</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46023</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.428571429</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46024</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.50877193</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46081</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.6</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46082</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.449275362</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46137</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.829268293</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46138</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46193</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.694444444</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46194</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46249</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.388888889</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46250</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46303</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.740740741</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46304</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46359</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.156069364</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46360</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Aminoglycosides</td>
            </tr>
            <tr>
               <td>46424</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46425</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.846153846</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46426</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.724137931</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46505</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46506</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.714285714</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46507</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>9.433962264</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46595</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46596</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>19.230769231</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46597</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.47761194</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46680</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46681</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46682</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.317073171</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46683</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.882352941</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46772</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46773</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46774</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.142857143</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46775</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.084745763</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46873</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46874</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46875</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.083333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46876</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.862068966</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46976</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46977</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.564102564</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>46978</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.62962963</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47077</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47078</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47079</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>15.384615385</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47080</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.684563758</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47179</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47180</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47181</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.921568627</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47182</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.040268456</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47283</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47284</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47285</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.153846154</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47286</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.97826087</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47390</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47391</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47392</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.692307692</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47393</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.194805195</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47498</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47499</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47500</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.344827586</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47501</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.454545455</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47602</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47603</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47604</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.347826087</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47605</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.225806452</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47714</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47715</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.851851852</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47716</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.85106383</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47769</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.639344262</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47770</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.347826087</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47817</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>10.638297872</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47818</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.823529412</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47869</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>9.230769231</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47870</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.896551724</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47915</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.142857143</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47916</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.382978723</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47967</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.128205128</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>47968</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.25</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48021</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.869565217</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48022</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.886792453</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48077</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.12371134</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48078</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.921568627</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48135</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.405405405</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48136</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>10.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48193</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>8.270676692</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48194</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.369863014</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48249</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.602339181</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48250</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.352941176</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48305</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.666666667</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48306</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>7.692307692</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48361</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48362</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48415</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.054054054</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48416</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.754385965</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48471</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.918032787</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48472</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.47761194</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Carbapenems</td>
            </tr>
            <tr>
               <td>48536</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48537</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48538</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.615384615</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48619</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48620</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48621</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.225806452</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48712</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.703703704</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48714</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.351351351</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48799</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48800</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48801</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.142857143</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48802</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.960784314</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48891</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48892</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48893</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.142857143</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48894</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.310344828</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48987</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48988</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48989</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.25</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>48990</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.909090909</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49088</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49089</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49090</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.672897196</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49189</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49190</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49191</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>11.764705882</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49192</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.472222222</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49291</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49292</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49293</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>8.163265306</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49294</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.072463768</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49393</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49394</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49395</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49396</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>7.262569832</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49496</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>12.5</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49497</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49498</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.451612903</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49499</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.827586207</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49603</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49604</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49605</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>15.254237288</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49606</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.294478528</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49706</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49707</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49708</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.347826087</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49709</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.442176871</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49817</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49818</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>28.571428571</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49819</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.433962264</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49820</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.469273743</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49873</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.941176471</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49874</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49921</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.851851852</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49922</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>10.526315789</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49973</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.408450704</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>49974</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.225806452</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50021</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.081632653</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50022</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.166666667</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50073</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.034482759</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50074</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.127659574</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50125</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.727272727</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50126</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.923076923</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50179</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.263157895</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50180</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50235</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.472222222</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50236</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>13.793103448</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50293</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.086614173</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50294</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.545454545</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50347</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.389221557</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50348</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.761904762</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50401</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.338028169</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50402</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.054054054</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50457</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.711409396</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50458</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50511</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.673758865</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50512</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.571428571</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50567</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.285714286</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50568</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.153846154</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Ceftazidime</td>
            </tr>
            <tr>
               <td>50632</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50633</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50634</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50715</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50716</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50717</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.225806452</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50808</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50809</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50810</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.351351351</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50895</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50896</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50897</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.380952381</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50898</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.970873786</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50987</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50988</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50989</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.380952381</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>50990</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.709401709</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51085</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51086</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51087</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.127659574</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51088</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51188</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51189</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51190</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.851851852</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51289</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51290</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51291</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.692307692</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51292</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.666666667</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51391</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51392</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51393</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.921568627</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51394</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.378378378</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51495</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51496</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51497</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51498</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.162162162</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51602</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51603</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51604</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.615384615</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51605</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51710</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51711</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51712</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.779661017</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.204819277</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51814</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51815</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51816</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.173913043</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51817</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.290322581</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51925</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51926</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>14.285714286</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51927</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.851851852</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51928</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.127659574</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51981</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>51982</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52029</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.851851852</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52030</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.263157895</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52081</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.408450704</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52082</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52129</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.040816327</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52130</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.040816327</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52181</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.724137931</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52182</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.083333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52235</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52236</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.886792453</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52291</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.06185567</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52292</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52349</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.342281879</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52350</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52407</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.303030303</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52408</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52463</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.325581395</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52464</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52519</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.315789474</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52520</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.282051282</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52575</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.986754967</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52576</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.947368421</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52629</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.351351351</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52630</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.754385965</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52685</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.18579235</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52686</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.985074627</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Combined resistance (at least three of piperac. and tazob., fluoroq., ceftaz., aminogl.
                  and carbapenems)</td>
            </tr>
            <tr>
               <td>52750</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52751</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.846153846</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52752</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52833</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52834</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>14.285714286</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52835</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52926</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52927</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>20.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>52928</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.351351351</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53013</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53014</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53015</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53016</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.883495146</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53102</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53103</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53104</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.43902439</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53105</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>2.608695652</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53200</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53201</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53202</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.127659574</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53203</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.385964912</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53299</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53300</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.128205128</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53301</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.607476636</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53399</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53400</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53401</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.615384615</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53402</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53501</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53502</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53503</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.882352941</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53504</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>10.135135135</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53605</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53606</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53607</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.538461538</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53608</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.783783784</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53712</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53713</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53714</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.230769231</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53715</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.846153846</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53820</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53821</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53822</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.779661017</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53823</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.819277108</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53924</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53925</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53926</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.347826087</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>53927</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.516129032</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54035</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54036</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>28.571428571</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54037</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>11.111111111</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54038</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>9.574468085</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54091</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.451612903</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54092</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54139</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>9.433962264</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54140</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.263157895</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54191</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.714285714</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54192</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.451612903</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54239</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.081632653</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54240</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54289</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.631578947</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54290</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.127659574</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54343</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.464285714</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54344</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.886792453</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54397</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>8.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54398</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54453</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.040268456</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54454</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54511</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>10.606060606</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54512</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.479452055</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54567</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.651162791</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54568</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54623</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.578947368</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54624</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.564102564</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54679</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.622516556</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54680</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.947368421</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54733</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.405405405</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54734</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.50877193</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54789</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>11.475409836</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54790</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>7.462686567</td>
               <td>Pseudomonas aeruginosa</td>
               <td>Fluoroquinolones</td>
            </tr>
            <tr>
               <td>54854</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>54855</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>54856</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.921568627</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>54936</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>54937</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.571428571</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>54938</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.389830508</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55029</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55030</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55031</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.408450704</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55116</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55117</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55118</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.317073171</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55119</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55207</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55208</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55209</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.761904762</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55210</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.539823009</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55303</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55304</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55305</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>6.666666667</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55306</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.754385965</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55400</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55401</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.564102564</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55402</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.882352941</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55501</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>33.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55502</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55503</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.416666667</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55504</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.895104895</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55603</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>25.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55604</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55605</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>16.326530612</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55606</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.293706294</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55705</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55706</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55707</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.692307692</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55708</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>8.241758242</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55812</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>12.5</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55813</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55814</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.692307692</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55815</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.575163399</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55920</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55921</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>14.545454545</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>55922</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.031446541</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56023</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>100.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56024</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56025</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.651162791</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56026</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.797101449</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56134</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56135</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>28.571428571</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56136</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>10.416666667</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56137</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.50877193</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56190</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.923076923</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56191</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.761904762</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56238</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.923076923</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56239</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.263157895</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56290</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.515151515</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56291</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56338</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>7.291666667</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56339</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.255319149</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56390</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.385964912</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56391</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.173913043</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56442</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.636363636</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56443</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.886792453</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56494</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.451612903</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56495</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.040816327</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56550</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.285714286</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56551</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>13.793103448</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56608</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>10.4</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56609</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.849315068</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56662</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>8.823529412</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56663</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.952380952</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56718</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.711409396</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56719</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.846153846</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56774</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>6.428571429</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56775</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>9.333333333</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56828</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.970149254</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56829</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.12244898</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56884</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.733727811</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56885</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.620689655</td>
               <td>Pseudomonas aeruginosa</td>
               <td>PiperacillinTazobactam</td>
            </tr>
            <tr>
               <td>56954</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>56955</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>56956</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>56957</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57045</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57046</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57047</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57048</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.840336134</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57139</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57140</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57141</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57142</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.35971223</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57243</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57244</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57245</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.558659218</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57246</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.357142857</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57351</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>6.25</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57352</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57353</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.985221675</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57354</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.358422939</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57459</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57460</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57461</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.568181818</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57462</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.289855072</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57571</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.857142857</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57572</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57573</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57574</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57679</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57680</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57681</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57682</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.224215247</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57791</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57792</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57793</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.729927007</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57794</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.6</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57895</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57896</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57897</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.303951368</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>57898</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.380952381</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58000</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58001</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>2.083333333</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58002</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.142857143</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58003</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.161550889</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58110</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58111</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58112</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.475059382</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58113</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.272851296</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58222</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>7.142857143</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58223</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>2.857142857</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58224</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.165048544</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58225</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.849514563</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58334</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>1.754385965</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58335</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58336</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.967117988</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58337</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.471142521</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58445</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58446</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>2.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58447</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.941619586</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58448</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.081081081</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58560</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.43902439</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58561</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>2.222222222</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58562</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.865800866</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58563</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.215469613</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58676</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>2.702702703</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58677</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58678</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.609657948</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58679</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.902934537</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58792</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>3.846153846</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58793</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58794</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.830663616</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58795</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.627615063</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58908</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>5.714285714</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58909</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58910</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.422764228</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58911</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.508130081</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58964</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>58965</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2000</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59010</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.909090909</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59011</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2001</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59060</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.37037037</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59061</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2002</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59114</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.37593985</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59115</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2003</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.4784689</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59170</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.336700337</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59171</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2004</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59226</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59227</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.925925926</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59282</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59283</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.364963504</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59338</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.216450216</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59339</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59394</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.386100386</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59395</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.952380952</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59446</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.51457976</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59447</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59500</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.583941606</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59501</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.555555556</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59556</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.257400257</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59557</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.448430493</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59614</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.091703057</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59615</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.556420233</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59672</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.656455142</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59673</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.715563506</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59728</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.144640999</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59729</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.857632933</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59784</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.171458999</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59785</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.167315175</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59840</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.666666667</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59841</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.364963504</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59896</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.08577633</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59897</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.924214418</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59952</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.927835052</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>59953</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.866551127</td>
               <td>Staphylococcus aureus</td>
               <td>Meticillin (MRSA)</td>
            </tr>
            <tr>
               <td>60041</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>42.5</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60042</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>22.222222222</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60043</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>8.441558442</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60044</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>12.154696133</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60143</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>24.489795918</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60144</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60145</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.659090909</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60146</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>11.764705882</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60249</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>15.625</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60250</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>12.5</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60251</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>9.701492537</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60252</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>8.503401361</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60352</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60353</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>9.090909091</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60354</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>8.658008658</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60355</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.188925081</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60445</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>15.625</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60446</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60447</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.978723404</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60448</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.844106464</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60541</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>7.407407407</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60542</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60543</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.703703704</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60544</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.378378378</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60645</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>4.545454545</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60646</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60647</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.172413793</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60648</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>3.311258278</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60744</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>17.647058824</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60745</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>25.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60746</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>4.867256637</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60747</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.255319149</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60848</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60849</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60850</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.539823009</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60851</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.4</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60948</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>23.529411765</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60949</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>14.285714286</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60950</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.040816327</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>60951</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>4.411764706</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61055</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>8.333333333</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61056</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61057</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>2.068965517</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61058</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61158</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>7.142857143</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61159</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>9.090909091</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61160</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>5.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61161</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>5.194805195</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61264</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>9.090909091</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61265</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>12.5</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61266</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>3.75</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61267</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.153846154</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61377</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>15.384615385</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61378</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>50.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61379</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>7.36196319</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61380</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>6.15942029</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61444</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>16.265060241</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61445</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>12.5</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61498</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>15.137614679</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61499</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>7.818930041</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61552</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>10.915492958</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61553</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>8.389261745</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61606</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>8.480565371</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61607</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.734767025</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61654</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.4</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61655</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.479452055</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61706</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.914590747</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61707</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.383458647</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61760</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>3.521126761</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61761</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>4.545454545</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61816</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.905660377</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61817</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.263157895</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61872</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.182509506</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61873</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>3.389830508</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61926</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>2.409638554</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61927</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.172839506</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61980</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.025125628</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>61981</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.941176471</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>62034</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>4.198473282</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>62035</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>6.63507109</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>62088</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>5.405405405</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>62089</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.529953917</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>62144</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>9.05511811</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>62145</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>5.825242718</td>
               <td>Streptococcus pneumoniae</td>
               <td>Macrolides</td>
            </tr>
            <tr>
               <td>62233</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62234</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62235</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.858369099</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62236</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.996677741</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62335</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62336</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62337</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62338</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.038062284</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62441</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62442</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62443</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.362318841</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62444</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62546</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62547</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62548</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.423728814</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62549</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62643</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>3.125</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62644</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62645</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.416666667</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62646</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62744</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62745</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62746</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.888888889</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62747</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62851</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62852</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62853</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62854</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62951</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62952</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62953</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.6</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>62954</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.673400673</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63059</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63060</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63061</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63062</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63167</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>10.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63168</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63169</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.401869159</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63170</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.687285223</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63275</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>8.333333333</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63276</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63277</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.898734177</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63278</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.195219124</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63381</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63382</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63383</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.666666667</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63384</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.557632399</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63486</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63487</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63488</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>1.156069364</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63489</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>65+</td>
               <td>1.403508772</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63599</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>0-4</td>
               <td>6.25</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63600</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>5-18</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63601</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>19-64</td>
               <td>0.561797753</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63602</td>
               <td>R - resistant isolates proportion, by age</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>65+</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63666</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.538461538</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63667</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2005</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.3125</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63720</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.34965035</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63721</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2006</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.673400673</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63774</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63775</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2007</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.325732899</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63830</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63831</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2008</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.348432056</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63880</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.787401575</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63881</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2009</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63932</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.338983051</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63933</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2010</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.357142857</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63986</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>63987</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2011</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64042</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.699300699</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64043</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2012</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.388888889</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64098</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64099</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2013</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.0</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64152</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.10701107</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64153</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2014</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.520912548</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64206</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.388888889</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64207</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2015</td>
               <td>Norway</td>
               <td>Female</td>
               <td>1.877934272</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64262</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.37037037</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64263</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2016</td>
               <td>Norway</td>
               <td>Female</td>
               <td>2.173913043</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64316</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Male</td>
               <td>1.619433198</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64317</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2017</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.858369099</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64372</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Male</td>
               <td>0.363636364</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
            <tr>
               <td>64373</td>
               <td>R - resistant isolates proportion, by gender</td>
               <td>%</td>
               <td>2018</td>
               <td>Norway</td>
               <td>Female</td>
               <td>0.444444444</td>
               <td>Streptococcus pneumoniae</td>
               <td>Penicillins</td>
            </tr>
         </tbody>
      </table>
   </body>
</html>